Stimulant Use — Cocaine, Amphetamines, MDMA
USMLE Step 1 trap: Incorrectly applies beta-blockers to cocaine chest pain, missing the unopposed alpha-stimulation risk. Beta-blockers are contraindicated in cocaine-induced chest pain because unopposed alpha-adrenergic stimulation worsens coronary vasospasm; benzodiazepines and nitroglycerin are preferred.
Stimulant use disorders — cocaine, amphetamines, methamphetamine, and MDMA — are high-yield for USMLE Step 1 because they test both pharmacology and clinical management in one package. The exam hits this topic from multiple angles: recognizing the sympathomimetic toxidrome, managing cocaine-specific complications correctly, distinguishing stimulant withdrawal from the dangerous withdrawals (alcohol, benzos), and knowing MDMA's unique profile. The tricky part isn't identifying that cocaine is involved — it's applying the right management when the stakes are highest, like chest pain in a young person.
The cocaine chest pain scenario is where students lose the most points. The reflex to give beta-blockers for chest pain with tachycardia and hypertension is strong — and exactly wrong here. USMLE Step 1 loves testing whether you understand the mechanism behind the contraindication, not just memorizing it. Similarly, MDMA questions require you to hold two pathophysiologic mechanisms in your head simultaneously rather than picking the simpler answer.
Withdrawal is another classic trap. Students over-pattern-match to alcohol withdrawal and assume stimulant withdrawal requires urgent intervention. It doesn't. The stimulant crash is miserable but not dangerous — the exam will give you a clinical scenario and expect you to correctly triage it as supportive care only, not intensive monitoring for seizures or delirium.
Common misconceptions
What the exam tests
- Recognize the full sympathomimetic toxidrome — tachycardia, hypertension, hyperthermia, diaphoresis, mydriasis — and identify cocaine or amphetamine as the cause in a clinical vignette.
- Manage cocaine-induced chest pain correctly: know why benzodiazepines and nitroglycerin are first-line and why beta-blockers are actively contraindicated due to unopposed alpha-adrenergic stimulation causing worsened coronary vasospasm.
- Identify stimulant withdrawal (the 'crash') by its features — dysphoria, hypersomnia, increased appetite, fatigue — and correctly classify it as not medically dangerous, requiring only supportive care.
- Recognize MDMA-specific complications: hyponatremia driven by both polydipsia AND SIADH-like ADH secretion, serotonin syndrome risk (especially with co-ingestion of serotonergic drugs), and hyperthermia.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →